EcoDrugPlus

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSAMXG00000007117
Gene Symbol: MST1R
2 Cross references
194 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSAMXG00000038370
Gene Symbol: MMP1
4 Cross references
305 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSAMXG00000033354
Gene Symbol: MMP14
3 Cross references
199 Possible Orthologues:

Matrix Metallopeptidase 14b (Membrane-Inserted)

Ensembl ID : ENSAMXG00000020970
Gene Symbol: MMP14B
1 Cross references
198 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSAMXG00000037117
Gene Symbol: MMP9
1 Cross references
215 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSAMXG00000007722
Gene Symbol: MMP9
1 Cross references
215 Possible Orthologues:

Matrix Metalloproteinase-20-Like

Ensembl ID : ENSAMXG00000038770
Gene Symbol: LOC103027284
2 Cross references
165 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSAMXG00000014520
Gene Symbol: MTOR
3 Cross references
224 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSAMXG00000026088
Gene Symbol: MC3R
1 Cross references
139 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSAMXG00000041719
Gene Symbol: MC4R
2 Cross references
202 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSAMXG00000026350
Gene Symbol: MC4R
1 Cross references
153 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSAMXG00000038683
Gene Symbol: MTNR1A
1 Cross references
138 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).